Literature DB >> 9130446

Transgenic remodeling of the regulatory myosin light chains in the mammalian heart.

J Gulick1, T E Hewett, R Klevitsky, S H Buck, R L Moss, J Robbins.   

Abstract

The regulatory myosin light chain (MLC) regulates contraction in smooth muscle. However, its function in striated muscle remains obscure, and the different functional activities of the various isoforms that are expressed in the mammalian heart (ventricle- and atrium-specific MLC2) remain undefined. To begin to explore these issues, we used transgenesis to determine the feasibility of effecting a complete or partial replacement of the cardiac regulatory light chains with the isoform that is normally expressed in fast skeletal muscle fibers (fast muscle-specific MLC2). Multiple lines of transgenic mice were generated that expressed the transgene at varying levels in the heart in a copy number-dependent fashion. There is a major discordance in the manner in which the different cardiac compartments respond to high levels of overexpression of the transgene. In atria, isoform replacement with the skeletal protein was quite efficient, even at low copy number. The ventricle is much more refractory to replacement, and despite high levels of transgenic transcript, protein replacement was incomplete. Replacement could be further increased by breeding the transgenic lines with one another. Despite very high levels of transgenic transcript in these mice, the overall level of the regulatory light chain in both compartments remained essentially constant; only the protein isoform ratios were altered. The partial replacement of the ventricular with the skeletal isoform reduced both left ventricular contractility and relaxation, although the unloaded shortening velocity of isolated ventricular cardiomyocytes was not significantly different.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130446     DOI: 10.1161/01.res.80.5.655

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

1.  Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology.

Authors:  J James; H Osinska; T E Hewett; T Kimball; R Klevitsky; S Witt; D G Hall; J Gulick; J Robbins
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

Review 2.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

3.  Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner.

Authors:  Petra E M H Habets; Danielle E W Clout; Ronald H Lekanne Deprez; Marian A van Roon; Antoon F M Moorman; Vincent M Christoffels
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  Functional properties of skinned rabbit skeletal and cardiac muscle preparations containing alpha-cardiac myosin heavy chain.

Authors:  Oleg Andruchov; Yishu Wang; Olena Andruchova; Stefan Galler
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

5.  Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.

Authors:  M C Colbert; D G Hall; T R Kimball; S A Witt; J N Lorenz; M L Kirby; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

6.  Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy.

Authors:  Qinghang Meng; Bidur Bhandary; Md Shenuarin Bhuiyan; Jeanne James; Hanna Osinska; Iñigo Valiente-Alandi; Kritton Shay-Winkler; James Gulick; Jeffery D Molkentin; Burns C Blaxall; Jeffrey Robbins
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

Review 7.  Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.

Authors:  Brian R Thompson; Joseph M Metzger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

8.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1.

Authors:  M A Sussman; S Welch; A Walker; R Klevitsky; T E Hewett; R L Price; E Schaefer; K Yager
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

9.  Charged residue alterations in the inner-core domain and carboxy-terminus of alpha-tropomyosin differentially affect mouse cardiac muscle contractility.

Authors:  Robert D Gaffin; Carl W Tong; David C Zawieja; Timothy E Hewett; Raisa Klevitsky; Jeffrey Robbins; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

10.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.